RPMI 1640培养基

注册证号 ：详询

英文名 ：详询

CAS号 ：详询

库存 ：大量

供应商 ：北京百奥创新科技有限公司

肿瘤类型 ：详询

细胞类型 ：详询

ATCC Number ：详询

品系 ：详询

组织来源 ：详询

相关疾病 ：详询

物种来源 ：详询

免疫类型 ：详询

细胞形态 ：详询

是否是肿瘤细胞 ：详询

器官来源 ：详询

运输方式 ：2-8℃

年限 ：详询

生长状态 ：详询

规格 ：500 ML

RPMI 1640 Medium was developed at Roswell Park Memorial Institute in 1966 by Moore and his co-workers. A modification of McCoy′s 5A Medium, it was formulated to support lymphoblastoid cells in suspension culture, but it has since been shown to support a wide variety of cells that are anchorage dependent.RPMI 1640 Medium was developed at Roswell Park Memorial Institute in 1966 by Moore and his co-workers. A modification of McCoy′s 5A Medium, it was formulated to support lymphoblastoid cells in suspension culture, but it has since been shown to support a wide variety of cells that are anchorage-dependent. Originally intended to be used with a serum supplement, RPMI 1640 has been shown to support several cell lines in the absence of serum. It has also been widely used in fusion protocols and in the growth of hybrid cells. This medium is suitable for culturing human normal and neoplastic leukocytes.